Ledger.Open graph →
SEC Form D · filed May 17, 2018

Xollent Biotech, Inc

Offering
$1.0M
Sold
$50K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
RALEIGH, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Ke Cheng · Raleigh, NCExec · DirectorDongmei Zhu · Raleigh, NCExecWeili Zhou · Raleigh, NCDirectorAnat Cohen-Dayag · Holon, L3Exec · DirectorKinneret L. Savitzky · Holon, L3ExecDavid Briskie · Chula Vista, CAExecChad Feigel · Chicago, ILExec · DirectorWeili Zhou · Raleigh, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗